Assertio Holdings | DEPO - Operating Profit

Stock Price
22.51
Daily Change
0.14 0.62%
Monthly
24.91%
Yearly
146.00%
Q2 Forecast
18.09

Assertio Holdings reported $-3.05M in Operating Profit for its fiscal quarter ending in September of 2024.





Operating Profit Change Date
ANI Pharmaceuticals USD 38.71M 9.58M Mar/2026
Assertio Holdings USD -3.05M 569K Sep/2024
Aurora Cannabis CAD -35.79M 19.88M Dec/2025
Cara Therapeutics USD -5.94M 3.55M Sep/2025
Daiichi Sankyo JPY 89.54B 42.01B Dec/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
J&J USD 6.62B 1.03B Mar/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Merck USD -1.88B 8.12B Mar/2026
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Omeros USD -35.41M 23.75M Sep/2024
Pfizer USD 4.99B 340M Mar/2026
Teva Pharmaceutical Industries USD 758M 271M Mar/2026